🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8796270

N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or

GILEAD CONNECTICUT, INC. · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8790652

Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules

VACCINEX, INC. · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8791116

Myosin light chain kinase inhibitor compounds, compositions and related methods of use

Northwestern University · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785487

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785429

Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

Takeda Pharmaceutical Company Limited · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785377

Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785444

Thiazoles and pyrazoles useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8779001

Stat3 inhibitors

The United States of America Dept. of Health and Human Services (DHHS) · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778876

Small-molecule inhibitors of Dengue and West Nile virus proteases

The Board of Regents of the University of Texas System · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778938

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8779197

Aryl amides useful as inhibitors of voltage-gated sodium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778980

Heterocyclic aspartyl protease inhibitors

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8771665

Inhibitors of hepatitis C virus polymerase

COCRYSTAL, DISCOVERY, INC. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8772495

5-lipoxygenase-activating protein inhibitor

Panmira Pharmaceuticals, LLC · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8772288

Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitog

Almirall, S.A. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8772238

Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765797

TG2 inhibitors and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765761

6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyra

GILEAD CONNECTICUT, INC. · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765802

Kinase inhibitors, compositions thereof, and methods of use therewith

United States of America as represented by the Department of Health and Human Resources NIH · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765817

Selective inhibitors of EG5 motors and methods of use

Arrowhead Center, Inc. · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765751

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8759332

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8759392

Amides as inhibitors of human secreted phospholipase A2

The Regents of the University of California · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8759389

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted